Mega-High-Throughput Screening Platform for the Discovery of Biologically Relevant Sequence-Defined Non-Natural

Michal Avital-Shmilovici1, Xiaohe Liu1, Thomas Shaler1

  • 1SRI Biosciences Division, SRI International, Menlo Park, California 94025, United States.

ACS Central Science
|February 2, 2022
PubMed
Summary

We developed a novel ultra-high-throughput screening platform to rapidly screen and sequence massive chemical libraries. This technology accelerates molecular discovery by overcoming previous bottlenecks in analyzing billions of synthetic compounds.

Related Concept Videos